| Dr Parisa Aghdas Moussavian, | |
|
6846 Reseda Blvd, Reseda, CA 91335-8509 | |
| (818) 514-1684 | |
| Not Available |
| Full Name | Dr Parisa Aghdas Moussavian |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 6846 Reseda Blvd, Reseda, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174193791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 106292 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Parisa Aghdas Moussavian, 4440 Honeyglen Ct, Moorpark, CA 93021-2742 Ph: (805) 660-9077 | Dr Parisa Aghdas Moussavian, 6846 Reseda Blvd, Reseda, CA 91335-8509 Ph: (818) 514-1684 |
News Archive
By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan's call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer's disease that afflicted former President Ronald Reagan prior to his recent death
A chemist at the National Institute of Standards and Technology has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.
Hard to Treat Diseases, Inc. announces that the company has commenced to subscribe to Pink Sheets news and filing service after a brief absence.
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.
› Verified 6 days ago
Paul Dorel Zau, Dentist Medicare: Not Enrolled in Medicare Practice Location: 6857 Reseda Blvd, Suite A, Reseda, CA 91335 Phone: 818-343-9000 | |
Michelle Shahisaman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 7941 Etiwanda Ave, Reseda, CA 91335 Phone: 818-422-4310 | |
Inna Kagan, DDS Dentist Medicare: Medicare Enrolled Practice Location: 17720 Sherman Way, Reseda, CA 91335 Phone: 818-705-0111 Fax: 818-705-2281 | |
Dr. Helen Shokri Torabzadeh, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 18437 Saticoy Street, # 3, Reseda, CA 91335 Phone: 818-705-4025 Fax: 818-705-4026 | |
Dr. Grisel Del Cueto, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 18440 Sherman Way, Reseda, CA 91335 Phone: 818-774-9709 Fax: 818-827-3086 | |
Mr. Arnulfo Molina, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 17756 Saticoy St, Reseda, CA 91335 Phone: 818-705-4700 Fax: 818-705-1681 | |
Dr. Linda S Kapgan, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 19301 Saticoy St Ste D, Reseda, CA 91335 Phone: 818-772-4222 Fax: 818-772-1530 |